Page last updated: 2024-11-08

beta-D-ribopyranose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beta-D-ribopyranose : A D-ribopyranose with a beta-configuration at the anomeric position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID441481
CHEMBL ID1159662
CHEBI ID27476
SCHEMBL ID625216

Synonyms (24)

Synonym
ribose(pyranose form)
C08353
7296-60-8
beta-d-ribopyranose
1OGD
2DRI
1DRK
1DRJ
DB04286
CHEBI:27476 ,
(2r,3r,4r,5r)-oxane-2,3,4,5-tetrol
ribose (pyranose)
CHEMBL1159662
115794-07-5
SCHEMBL625216
beta-ribopyranose (9ci)
.beta.-d-ribopyranose
beta-d-ribose; d-ribose; ribose; ribose(pyranose form)
(2r,3r,4r,5r)-tetrahydro-2h-pyran-2,3,4,5-tetraol
Q27095107
ribopyranose, beta-d-
49X539P7H4 ,
unii-49x539p7h4
DTXSID001316622
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
D-ribopyranoseA D-ribose and the D-enantiomer of ribopyranose.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Ribose Degradation58
ribose phosphorylation210
superpathway of ribose and deoxyribose phosphate degradation024
ribose degradation07

Protein Targets (4)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, D-RIBOSE-BINDING PROTEINEscherichia coliKd0.10670.04000.10670.1500AID977611
Chain A, D-RIBOSE-BINDING PROTEINEscherichia coliKd0.10670.04000.10670.1500AID977611
Chain A, D-RIBOSE-BINDING PROTEINEscherichia coliKd0.10670.04000.10670.1500AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1811Experimentally measured binding affinity data derived from PDB1994The Journal of biological chemistry, Dec-02, Volume: 269, Issue:48
Probing protein-protein interactions. The ribose-binding protein in bacterial transport and chemotaxis.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1994The Journal of biological chemistry, Dec-02, Volume: 269, Issue:48
Probing protein-protein interactions. The ribose-binding protein in bacterial transport and chemotaxis.
AID1179557Binding affinity to Escherichia coli ribose binding protein by NMR analysis2014Journal of medicinal chemistry, Oct-09, Volume: 57, Issue:19
Elements and modulation of functional dynamics.
AID383287Binding affinity to Trypanosoma vivax IAG-nucleoside hydrolase2008European journal of medicinal chemistry, Feb, Volume: 43, Issue:2
Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.
AID440574Binding affinity to Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase assessed as S-sulfocysteine formation at pH 5.5 by single turnover method in absence of thioredoxin2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Identification of critical ligand binding determinants in Mycobacterium tuberculosis adenosine-5'-phosphosulfate reductase.
AID717236Binding affinity to Streptomyces avidinii streptavidin at 4 mM using dye labeled Streptavidin binding aptamer by fluorescence spectral analysis method2012Bioorganic & medicinal chemistry letters, Dec-01, Volume: 22, Issue:23
Specific interactions between adenosine and streptavidin/avidin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.55 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]